It was reported that the delta pressure increased during patient treatment.No visible clots were noted.The quadrox-id pediatric was exchanged with an hls set during patient treatment.The affected products were not available for technical investigation of the manufacturer.The reported event "delta pressure increased" was not investigated within a previous complaint.Thus the exact root cause of the reported event could not be determined.Therefore it was not possible to confirm the reported failure "delta pressure increased".However in accordance to the risk assessment (quadrox-id, pediatric) the reported failure could be linked to the following most probable root causes: -blockage of oxygenator, -increasing pressure drop, -impaired blood flow, -deteriorating gas transfer, -insufficient anticoagulation, -hemostasis.Based on the investigation results the reported failure could not be confirmed.The occurrence rate regarding the above complaint is below the acceptance rate.Thus, no remedial action required.The occurrence rate related to the reported issue is currently being monitored as part of maquet cardiopulmonary¿s trending program and additional investigations or corrections will be implemented in case of adverse trending.
|